You have a diagnosis. Here is what is published about treatment in China.
Medical information for international patients. Search 25 conditions for published cost ranges, outcome figures, hospitals with a source record and registered clinical trials - every figure names where it came from.
Or start from where you are:
What one condition page answers
Four questions, four answers, each one opening the record it came from:
Lung cancer肺癌
ICD-10: C34 — Malignant neoplasm of bronchus and lung
- Treatment cost ranges 5 published ranges, each with its source on the row page
- Five-year survival 28.7% 95% CI 28.6–28.9 · 2019–2021
- Hospitals with a published record 8 for this condition, each with its published source
- Clinical trials 121 recruiting or not yet recruiting, as published
Shown as an example of what every condition page carries - not a recommendation of any hospital or treatment. Figures are quoted as published, with their year and their caliber.
- 25 conditions covered
- 731 hospitals listed
- 112 cost ranges
- A · B · C evidence level on every row
Understanding care in China
Short guides to how the Chinese health system actually works: where patients go and why, what the national rankings do and do not say, and how this site decides which hospitals it lists.
Each guide is written in plain language and names its sources. They describe how the system works; they do not recommend a hospital or a doctor, and they are not medical advice.

Browse by category
Five ways in, one rule: nothing is published without a source and a level.
-

Diseases
Condition overviews, ICD codes and the evidence level of each row.
25 conditions
-

Hospitals
Hospital profiles with region, grade, national key specialties and sources.
731 hospitals
-

Services
Practical help with the steps around treatment, from second opinion to translation.
4 services
-

News
Updates, each with an AI-assisted summary and a link back to the original source.
22 updates
-

Methodology
How this site decides what to publish, how each row is graded, and what stays unknown.
Evidence levels A · B · C
Latest updates
- Phase 1 trial of in vivo CAR-T therapy for relapsed AML registered in Beijing
- Phase 2 lung cancer trial with Chinese sites is recruiting
- Phase 3 trial of an autologous cell therapy for COPD registered at a Guangzhou hospital
- Phase 2 colorectal cancer trial opens at Guangdong Provincial People’s Hospital
- Guangdong runs a cross-border exercise for its Hong Kong-Macao drug and device scheme
Help with the practical side
Four services for the steps around treatment. Online payment is not open yet, so every button below is disabled while we finish the agreements.
Expedited admission can be arranged once your records are ready, subject to the hospital's confirmed schedule.
-

Second opinion
Get a Chinese hospital's written view on your case before you travel.
Contact us to arrange -

Visa guidance
Work out which visa fits a medical trip, and what the hospital has to issue.
Contact us to arrange -

On-the-ground support
Someone with you from the airport through the appointments and back.
Contact us to arrange -

Medical translation
Your records, in the language the hospital reads.
Contact us to arrange
See what each service covers, and what stays with the hospital